Papaverine, a potent inhibitor of respiration in C-6 astrocytoma cells
Browning, E.T.; Groppi, V.E.; Kon, C.
Molecular Pharmacology 10(1): 175-181
1974
ISSN/ISBN: 0026-895X PMID: 4367754 Document Number: 81514
Document emailed within 1 workday
Related Documents
Lipkin, G.; Knecht, M.E.; Rosenberg, M. 1978: A potent inhibitor of normal and transformed cell growth derived from contact-inhibited cells Cancer Research 38(3): 635-643Hibasami, H.; Sakurai, M.; Maekawa, S.; Nakashima, K. 1987: Methylthiopropylamine, a potent inhibitor of spermidine synthase and its antiproliferative effect on human lymphoid leukemia Molt 4B cells Anticancer Research 7(6): 1213-1216
Falo, L.D.; Benacerraf, B.; Rothstein, L.; Rock, K.L. 1987: Cerulenin is a potent inhibitor of antigen processing by antigen-presenting cells Journal of Immunology 139(12): 3918-3923
Hirano, T.; Yotsumoto, T.M.; Ando, K.; Tobe, T. 1991: Changes of acinar cells in the pancreato-biliary duct ligation with exocrine pancreatic stimulation model in rats; protective effects of a new potent protease inhibitor, ONO3307 Nihon Geka Hokan. Archiv für Japanische Chirurgie 60(5): 342-353
Murphy, N.R.; Leinbach, S.S.; Hellwig, R.J. 1995: A potent, cost-effective RNase inhibitor Biotechniques 18(6): 1068-1073
Malkovský, M.; Asherson, G.L.; Chandler, P.; Colizzi, V.; Watkins, M.C.; Zembala, M. 1983: Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells Journal of Immunology 130(2): 785-790
Wen, X.; Wang, J.S.; Backman, J.T.; Kivistö, K.T.; Neuvonen, P.J. 2001: Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9 Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(11): 1359-1361
Brugge, W.R.; Rosenfeld, M.S. 1987: Impairment of starch absorption by a potent amylase inhibitor American Journal of Gastroenterology 82(8): 718-722
Kawai, K.; Shiojiri, H.; Fukushima, H.; Nozawa, Y.; Hasegawa, J.; Nozaki, M.; Tsurumi, K.; Fujimura, H. 1984: The effect of clidanac, a potent anti-inflammatory drug, on mitochondrial respiration: a consideration on the uncoupling activity of optical enantiomers Research Communications in Chemical Pathology and Pharmacology 45(3): 399-406
Skurský, L.; Khan, A.N.; Saleem, M.N.; al-Tamer, Y.Y. 1992: A new potent inhibitor of horse liver alcohol dehydrogenase: p-methylbenzyl hydroperoxide Biochemistry International 26(5): 899-904
Lin, J.H.; Chen, I.W.; Vastag, K.J.; Ostovic, D. 1995: pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(7): 730-735
Veres, Z.; Szinai, I.; Szabolcs, A.; Ujszászy, K.; Dénes, G. 1987: Biological activity of the potent uridine phosphorylase inhibitor 5-ethyl-2,2'-anhydrouridine Drugs under Experimental and Clinical Research 13(10): 615-621
Frye, S.V.; Bramson, H.N.; Hermann, D.J.; Lee, F.W.; Sinhababu, A.K.; Tian, G. 1998: Discovery and development of GG745, a potent inhibitor of both isozymes of 5 alpha-reductase Pharmaceutical Biotechnology 11: 393-422
Sabała, P.; Czarny, M.; Woronczak, J.P.; Barańska, J. 1993: Thapsigargin: potent inhibitor of Ca2+ transport ATP-ases of endoplasmic and sarcoplasmic reticulum Acta Biochimica Polonica 40(3): 309-319
Hara, H.; Tamao, Y.; Kikumoto, R.; Funahara, Y.; Hijikata, A.; Okamoto, S. 1980: Effect of a potent thrombin inhibitor, No. 407, on platelet function in vitro and in vivo Kobe Journal of Medical Sciences 26(1): 47-60
Medina, J.H.; Novas, M.L.; De Robertis, E.; Pena, C.; Paladini, A.C. 1986: Identification of a potent endogenous benzodiazepine binding inhibitor from bovine cerebral cortex Advances in Biochemical Psychopharmacology 42: 47-56
Chen, C.Y.; Tan, L. 1999: Chemical process evolution of efavirenz, a potent non-nucleosidal HIV reverse transcriptase inhibitor Enantiomer 4(6): 599-608
Hall, E.D.; Braughler, J.M.; Yonkers, P.A.; Smith, S.L.; Linseman, K.L.; Means, E.D.; Scherch, H.M.; Von Voigtlander, P.F.; Lahti, R.A.; Jacobsen, E.J. 1991: U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia Journal of Pharmacology and Experimental Therapeutics 258(2): 688-694
Trapani, A.J.; De Lombaert, S.; Erion, M.D.; Ghai, R.D.; Peppard, J.V.; Lappe, R.W.; Worcel, M. 1993: The pharmacology of CGS 25462: a potent, orally bioavailable, long-acting inhibitor of neutral endopeptidase 24.11 Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 11(5): S220-S221
Jones, T.R.; Charette, L.; Garcia, M.L.; Kaczorowski, G.J. 1990: Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor Journal of Pharmacology and Experimental Therapeutics 255(2): 697-706